当前位置: X-MOL 学术Lancet Infect Dis › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Global deworming: moving past albendazole and mebendazole
The Lancet Infectious Diseases ( IF 56.3 ) Pub Date : 2017-08-29 , DOI: 10.1016/s1473-3099(17)30484-x
Peter J Hotez

Since the 2001 adoption of the World Health Assembly (WHA) resolution calling for the global deworming of children affected by soil-transmitted helminth (STH) infections and schistosomiasis,1 the world's public health leaders have gradually responded. Although we are still behind schedule in terms of the WHA's original 2010 targets, WHO continues to report progress—in 2015, approximately 59% of the world's children requiring treatment received access to deworming medicines for their STH infections,2 mostly single-dose albendazole or mebendazole (each an anthelmintic drug in the benzimidazole drug class).

中文翻译:

全球驱虫:超越阿苯达唑和甲苯达唑

自2001年通过世界卫生大会(WHA)决议以来,该决议呼吁在全球范围内对受土壤传播的蠕虫(STH)感染和血吸虫病侵袭的儿童进行驱虫,1全球公共卫生领导人对此作出了逐步反应。尽管在WHA最初的2010年目标方面我们仍然落后于时间表,但WHO仍在报告进展情况-在2015年,需要治疗的全球约59%的儿童因STH感染而获得了驱虫药,其中2种主要是单剂量的阿苯达唑或甲苯咪唑(每种苯并咪唑类驱虫药)。
更新日期:2017-08-30
down
wechat
bug